KIT-2014

N/A

Report date: 2024/11/15 20:00:35

Base Information

Drug NameKIT-2014
Drug Alias NamePhosphoinositide 3-kinase gamma peptideKIT-2014
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPhosphatidylinositol 3 kinase gamma inhibitors
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gamma
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKither Biotech SRL
China Registration ClassN/A

Develop Information

Active CompaniesPantherna Therapeutics GmbHKither Biotech SRL
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A